1.Prevalence of Symptomatic Reherniation After Lumbar Discectomy Using a Bone-Anchored Annular Closure Device and Associated Contributing Factors: A MetaAnalysis
Al-Gunaid ST ; Iqhrammullah M ; Maulana G ; Qanita I ; Adista MA ; Hidayat I
Malaysian Orthopaedic Journal 2026;20(No. 1):45-
Introduction: The primary issue following lumbar
discectomy for disc herniation is the risk of reherniation in
the post-operative period. Many surgical techniques have
been proposed to treat disc reherniation, however, the
optimal one remains variable. This meta-analysis aimed to
investigate the prevalence of symptomatic reherniation after
using a Bone-anchored annular closure device following
lumbar discectomy and the contributing factors.
Materials and methods: Identification of published
literature was performed on PubMed, Google Scholar,
Scopus, and Web of Science databases. Studies published
until 14 February 2024 reported the prevalence of
symptomatic reherniation after using a Bone-anchored
annular closure device following lumbar discectomy and the
associated contributing factors. A random effects model was
used to conduct Bayesian frequentist network meta-analysis
and pair-wise meta-analysis, with the assessment based on
standardised mean difference (SMD) and 95% confidence
interval (CI).
Results: Eleven studies published in 2012 − 2022 recruiting
a total of 5195 patients were included in the meta-analysis.
The prevalence of reherniation in ACD and control groups
was 23.2% (95% CI: 18.2% − 28.1%) and 36.4% (95% CI:
28.2% − 44.5%), respectively. The moderator effect of
sample size is significant for pooled data of the ACD group
(p-mod=0.002), but not for the control group (pmod=0.278). After the adjustment with sample size, the
prevalence rates were 13.6% (95% CI: 6.2% − 21.1%) and
29.6% (95% CI: 14.9% − 33.2%) for ACD and control
groups, respectively.
Conclusion: Comparatively to lumbar discectomy alone,
using a Bone-anchored annular closure device following
lumbar discectomy decreased the symptomatic reherniation
rate and post-operative complications, as well as the
necessity for subsequent surgeries.
2.Thumb Reconstruction Using a Modified Masquelet Technique Following Crush Injury: A Case Report
Ahmad-Faris MK ; Vijayan G ; Ankimtay R
Malaysian Orthopaedic Journal 2026;20(No. 1):69-
Traumatic crush injury of the thumb is devastating and often
resulted in poor functional outcome. Various reconstruction
options available according to surgical expertise. Masquelet
technique is well-established in the long bones of lower
limb. Only a handful of cases reported for thumb, especially
in Asia region. We described a case of crush injury of right
thumb following a trauma. The bony defect was initially
filled with antibiotic spacer and subsequent reconstruction
with tricortical iliac graft, a modified Masquelet two-stage
technique. It is a versatile tool which provide satisfactory
functional outcome and hand appearance.
3.Analysis of the Capacities of Health Facilities in the Eastern Visayas Region based on Health Care Provider Network Service Delivery Guidelines.
Leizel P. LAGRADA ; Romulo F. NIEVA ; Alvin Duke R. SY ; Kim Leonard G. DELA LUNA ; Darrlyn Normaine P. BERNABE ; Fernando B. GARCIA ; He Yeon Ji ; Romil Jeffrey R. JUSON ; Jasper M. MAGLINAB ; Jihwan Jeon
Acta Medica Philippina 2026;60(3):13-26
OBJECTIVES
Timely access to appropriate levels of care is essential for improving maternal, newborn,
and child health outcomes. To address persistent service delivery fragmentation and strengthen referral systems, the Philippine Department of Health issued Administrative Order 2020-0019 to guide the design of Health Care Provider Networks (HCPNs) under the Universal Health Care Act of 2019. This study assessed the extent to which sixteen municipalities across four provinces in Eastern Visayas comply with the HCPN service delivery guidelines in the context of maternal and newborn care.
The study employed a descriptive cross-sectional mixed-methods design, utilizing structured facility checklists to assess compliance with HCPN standards. Qualitative data were gathered through key informant interviews and focus group discussions with purposively selected stakeholders—decision makers, health personnel, and mothers—to contextualize findings. A three-lever framework for integrated care (policy, operational, and cross- cutting) guided the analysis
RESULTSThe findings revealed significant gaps between the current capacities of study health facilities and the requirements outlined in the HCPN guidelines. Major gaps included (1) weak cooperative governance mechanisms to support network-wide coordination; (2) limited systematic linkages between facilities, including fragmented referral protocols and non-interoperable health information systems; (3) inadequate investments in infrastructure, health human resources, and medical commodities; and (4) absence of performance monitoring systems across HCPNs.
CONCLUSION
Human ; Information Systems ; Occupational Groups ; Referral And Consultation ; Universal Health Care ; Delivery Of Health Care
4.Transforming outcomes: the pivotal role of self-expanding metal stents in right- and left-sided malignant colorectal obstructions-bridge to surgery: a comprehensive review and meta-analysis
Sheza MALIK ; Priyadarshini LOGANATHAN ; Hajra KHAN ; Abul Hasan SHADALI ; Pradeep YARRA ; Saurabh CHANDAN ; Babu P. MOHAN ; Douglas G. ADLER ; Shivangi KOTHARI
Clinical Endoscopy 2025;58(2):240-252
Background/Aims:
Self-expanding metallic stents (SEMS) are an alternative to emergency surgery (ES) for malignant colorectal obstruction. This study aimed to compare surgical outcomes between SEMS as a bridge to surgery (BTS) and ES in patients with malignant colorectal obstruction.
Methods:
A comprehensive database search was conducted until October 2023 to compare outcomes between SEMS as a BTS and ES. A subgroup analysis of results by malignancy site was performed.
Results:
We analyzed 57 studies, including 7,223 patients over a mean duration of 35.4 months. SEMS as a BTS showed clinical and technical success rates of 88.0% (95% confidence interval [CI], 86.1%–90.1%; I2=68%) and 91.6% (95% CI, 89.7%–93.7%; I2=66%), respectively. SEMS as a BTS revealed reduced postoperative adverse events (odds ratio [OR], 0.51; 95% CI, 0.41–0.63; I2=70%; p<0.001) and 30-day mortality (OR, 0.52; 95% CI, 0.37–0.72; I2=10%; p<0.001) compared to ES. Subgroup analysis showed postoperative mortality of 5% and 1.5% for left- and right-sided malignancies, respectively. Adverse events were 15% and 33% for the right and left colon, respectively.
Conclusions
SEMS as a BTS demonstrated a higher success rate, fewer postoperative adverse events, and a reduced 30-day mortality rate than ES, supporting its use as the preferred initial intervention for right- and left-sided obstructions and indicating broader clinical adoption.
6.Prevalence of intestinal metaplasia, dysplasia, and esophageal adenocarcinoma in patients with irregular Z-line: a systematic review and meta-analysis
Vishali MOOND ; Pradeep YARRA ; Mannat BHATIA ; Sheza MALIK ; Vineel MALAVARAPPU ; Hassam ALI ; Saurabh CHANDAN ; Douglas G. ADLER ; Babu P. MOHAN
Clinical Endoscopy 2025;58(3):377-385
Background/Aims:
The irregular Z-line, defined as a segment of columnar mucosa less than 1 cm in the distal esophagus, is often biopsied despite guidelines advising against it due to a low risk of progression to esophageal adenocarcinoma (EAC). However, the clinical significance of an irregular Z-line remains unclear. This meta-analysis examines the prevalence of Barrett’s esophagus, dysplasia, and EAC in patients with an irregular Z-line.
Methods:
We searched Medline, Embase, and Scopus databases up to October 2023 for studies on the prevalence of Barrett’s esophagus, dysplasia, and EAC in these patients. A random-effects model was used for meta-analysis, and heterogeneity was assessed using I2 statistics.
Results:
Nine studies involving 17,637 patients were analyzed. Among those with an irregular Z-line, the prevalence of intestinal metaplasia was 29.4%. In patients with intestinal metaplasia, dysplasia was found in 6.2%, low-grade dysplasia in 5.9%, high-grade dysplasia in 1.6%, and EAC in 1.5%. These rates were higher compared to those without intestinal metaplasia.
Conclusions
Patients with an irregular Z-line and intestinal metaplasia may be at higher risk and could benefit from endoscopic surveillance. Further studies are needed to determine the necessity of biopsying irregular Z-lines.
7.Historical Perspectives of the Korean Society for Thoracic and Cardiovascular Surgery: Sung Nok Hong (1927–2017) Who Performed the First Coronary Artery Bypass Graft in Korea
Doo Yun LEE ; Hyo Chae PAIK ; Byung Chul CHANG ; Meyun-Shick KANG ; Kook-Yang PARK
Journal of Chest Surgery 2025;58(2):73-76
8.Whole-genome sequencing of SARS-CoV-2 from residual viral RNA present on positive rapid antigen test kits for genomic surveillance
Mohd Ishtiaq Anasir ; Khayri Kamel ; Nor Malizza G Adypatti ; Mohammad Syafiq Jamaluddin ; Farah Amira Ahmad ; Siti Nurhidayah Norhisham ; Muhammad Zulfazli Mohamad Sukri ; Nur Rafiqah Rosli ; Siti Norazrina Saif ; Nurul Izzati Basarudin ; Mohamad Azzam-Sayuti ; Akmal Hayat Abdul Karim ; Mahirah Kamil Puat ; Ravindran Thayan ; Rozainanee Mohd Zain
Western Pacific Surveillance and Response 2025;16(1):06-11
This report describes an approach to recover SARS-CoV-2 RNA from rapid antigen test kit (RTK-antigen) cassettes for whole-genome sequencing (WGS). RNA samples were recovered from 33 RTK-antigen cassettes for WGS, with 18 samples achieving more than 80% genome coverage. This work provides a proof-of-concept that positive RTK-antigen cassettes can be safely transported, stored and subjected to WGS, enabling swift identification of circulating variants.
9.Monitoring mortality in the setting of COVID-19 pandemic control in Victoria, Australia: a time series analysis of population data
Lalitha Sundaresan ; Sheena G Sullivan ; David J Muscatello ; Daneeta Hennessy ; Stacey L Rowe
Western Pacific Surveillance and Response 2025;16(1):29-39
Objective: Mortality surveillance was established in the state of Victoria just before the COVID-19 pandemic. Here, we describe the establishment of this surveillance system, justify the modelling approach selected, and provide examples of how the interpretation of changes in mortality rates during the pandemic was influenced by the model chosen.
Methods: Registered deaths occurring in Victoria from 1 January 2015 to 31 December 2020 were sourced from the Victoria Death Index. Observed mortality rates were compared to a raw historical 5-year mean and to predicted means estimated from a seasonal robust regression. Differences between the observed mortality rate and the historical mean (delta-MR) and excess mortality rate from the observed and predicted rates were assessed.
Results: There were 20 375 COVID-19 cases notified in Victoria as of 31 December 2020, of whom 748 (3.7%) died. Victorians aged >=85 years experienced the highest case fatality ratio (34%). Mean observed mortality rates in 2020 (MR: 11.6; 95% confidence interval [CI]: 11.4, 11.9) were slightly reduced when compared with the annual rate expected using the historical mean method (mean MR: 12.2; 95% CI: 12.1, 12.3; delta-MR: -0.57; 95% CI: -0.77, -0.38), but not from the rate expected using the robust regression (estimated MR: 11.7; 95% prediction interval [PI]: 11.5, 11.9; EMR: -0.05; 95% CI: -0.26, 0.16). The two methods yielded opposing interpretations for some causes, including cardiovascular and cancer mortality.
Discussion: Interpretation of how pandemic restrictions impacted mortality in Victoria in 2020 is influenced by the method of estimation. Time-series approaches are preferential because they account for population trends in mortality over time.
10.Effects of flavanone on cancer cells viability
Jadamba Ch ; Erdenezaya O ; Iderjavkhlan S ; Burnee M ; Gurbadam A ; Temuulen D ; Darambazar G ; Oldokh O ; Enkhmaa D ; Giimaa N
Mongolian Journal of Health Sciences 2025;88(4):28-32
Background:
In recent years, scientists have found that certain natural compounds have significant potential in cancer
prevention and early-stage cancer treatment. Flavanones, a class of polyphenolic compounds found in plants, vegetables,
seeds, fruit peels, and flowers, have been identified to possess anticancer, antioxidant, anti- inflammatory, and antibacterial bioactivities. Cancer has become a major global challenge in terms of both economic and public health concerns.
Global statistics indicate that 22.8% of deaths are attributed to non-communicable diseases, and 16.8% are caused by
cancer, accounting for one in four and one in six deaths, respectively.
Aim :
To investigate anticancer effects of Iris Tenuifolia-derived flavanone on cancer cell lines.
Materials and Methods :
The study was conducted at the Bio-Medical Research Institute of the Mongolian National Uni
versity of Medical Sciences, investigating the effect of flavanones on cancer cell viability under in vitro conditions using
the MTT assay. In the study, colon, liver, and lung cancer cells were cultured, stabilized, and used for the experiments.
Colorectal cancer cells (MC38), liver cancer cells (HepG2), and lung cancer cells (A549) were revived, cultured, and
stabilized for use in the experimental procedures. Statistical analysis of the results was performed using Microsoft Excel
2010, and graphs were generated using GraphPad Prism 8. Differences between groups were analyzed using Student’s
t-test, and a p-value of <0.05 was considered statistically significant.
Results :
We treated MC38, HepG2, and A549 cancer cells with different concentrations of flavanone (2.5 µM, 5 µM, and
10 µM) for 24 to 48 hours to evaluate cell viability. Flavanone inhibited A549 cell viability by 2.5 μM-10%, 5 μM-25%,
and 10 μM-38%, respectively. For HepG2 cells, flavanone treatment at concentrations of 5-10 µM reduced cell viability by 28–58%. No statistically significant effect on the viability of MC38 cells was observed following treatment with flavanone at concentrations ranging from 2.5 to 10 µM. Additionally, although MC38 inhibited cell viability in a dose-de
pendent manner in cell cultures, it had a statistically significant effect at higher concentrations of 30-200 μM (p<0.01).
Conclusion
Flavanone inhibits the cancer cell viability in a dose and time dependent manner


Result Analysis
Print
Save
E-mail